Temozolomide
Pricing Report NDC 0781-2694-44

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Temozolomide (NDC 0781-2694-44) is $13.83623 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 21, 2021.

As a provided by Sandoz Inc., this medication is distributed in a 1 BOTTLE, GLASS in 1 CARTON / 14 CAPSULE in 1 BOTTLE, GLASS configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$13.83623
Per EA

Effective Date
Jul 21, 2021
Billable Units
1 EA
Estimated Package Price
$13.84
Data Status
As of Jul 13, 2022
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BOTTLE, GLASS in 1 CARTON / 14 CAPSULE in 1 BOTTLE, GLASS
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2014, the NADAC wholesale price for (NDC ) has moved within a range of $13.83623 to $249.30080 per EA. Over this 7 years and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$13.8362 - $249.3008
Market Volatility
1,701.80% Variance
Latest Trend
92.47%
Date Unit Price Unit Source Method Rate
Jul 21, 2021 $13.83623 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 21, 2021 $13.83623 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jul 21, 2021 $13.83623 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 21, 2021 $13.83623 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Nov 19, 2014 $183.77000 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $183.77000 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Nov 19, 2014 $183.77000 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $183.77000 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Aug 20, 2014 $191.11086 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $191.11086 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Aug 20, 2014 $191.11086 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $191.11086 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jul 23, 2014 $183.99137 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2014 $183.99137 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $249.30080 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $249.30080 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jan 22, 2014 $249.30080 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $249.30080 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026